Alexion Pharmaceuticals, Inc.
Synthesis of cerdulatinib
Last updated:
Abstract:
The present disclosure provides processes for the preparation of cerdulatinib, which is of formula I: ##STR00001## or a salt thereof. The disclosure also provides intermediates and processes for the preparation of the intermediates useful in the preparation of cerdulatinib or a salt thereof.
Status:
Grant
Type:
Utility
Filling date:
21 Oct 2020
Issue date:
24 May 2022